We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+9.33%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+596.65%
AUM
$759B
AUM Growth
+$62.2B
Cap. Flow
+$8.76B
Cap. Flow %
1.15%
Top 10 Hldgs %
15.99%
Holding
7,423
New
754
Increased
2,939
Reduced
2,285
Closed
593
Avg Time Held Equity + Options
17.2 quarters
Top 10 Avg Time Held Equity + Options
15.7 quarters
Top 20 Avg Time Held Equity + Options
12.9 quarters
Avg Time Held Equity only
18.8 quarters
Top 10 Avg Time Held Equity only
15.7 quarters
Top 20 Avg Time Held Equity only
15.1 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.19%
2 Technology 14.28%
3 Healthcare 12.84%
4 Financials 10.61%
5 Consumer Discretionary 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
COMS
6201
DELISTED
COMSovereign Holding Corp. Common Stock
COMS
$1K ﹤0.01%
70
– –
2022 Q1
3 quarters
NSTB
6202
DELISTED
Northern Star Investment Corp. II
NSTB
$1K ﹤0.01%
+81
New +$808
2022 Q4
0 quarters
TBLT
6203
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
$1K ﹤0.01%
+5
New +$731
2022 Q4
0 quarters
IMPL
6204
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$1K ﹤0.01%
359
-962
-73% -$3.51K
2021 Q2
6 quarters
IBDO
6205
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
$1K ﹤0.01%
35
-2,000
-98% -$49.9K
2020 Q3
9 quarters
AAIC
6206
DELISTED
Arlington Asset Investment Corp.
AAIC
$1K ﹤0.01%
622
-8
-1% -$24
2013 Q2
38 quarters
CZOO
6207
DELISTED
Cazoo Group Ltd
CZOO
$1K ﹤0.01%
2
-1
-33% -$592
2021 Q4
4 quarters
HWELU
6208
DELISTED
Healthwell Acquisition Corp. I Unit
HWELU
$1K ﹤0.01%
+58
New +$577
2022 Q4
0 quarters
CCV.WS
6209
DELISTED
Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCV.WS
– –
0
– –
2021 Q3
5 quarters
SURF
6210
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$1K ﹤0.01%
1,407
-2,351
-63% -$2.32K
2021 Q1
7 quarters
HARP
6211
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$1K ﹤0.01%
136
-114
-46% -$960
2019 Q1
15 quarters
SAL
6212
DELISTED
Salisbury Bancorp, Inc.
SAL
$1K ﹤0.01%
26
– –
2020 Q2
10 quarters
SPPI
6213
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$1K ﹤0.01%
3,924
-7,821
-67% -$3.3K
2016 Q4
24 quarters
TWCBW
6214
DELISTED
Bilander Acquisition Corp. Warrant
TWCBW
– –
0
– –
2022 Q2
2 quarters
VNTR
6215
DELISTED
Venator Materials PLC
VNTR
$1K ﹤0.01%
1,577
– –
2020 Q1
11 quarters
MSAC
6216
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$1K ﹤0.01%
100
– –
2021 Q4
4 quarters
ATNX
6217
DELISTED
Athenex, Inc. Common Stock
ATNX
$1K ﹤0.01%
172
-308
-64% -$1.17K
2017 Q4
20 quarters
SCMAW
6218
DELISTED
Seaport Calibre Materials Acquisition Corp. Warrant
SCMAW
– –
0
– –
2022 Q2
2 quarters
QED
6219
DELISTED
IQ Hedge Event-Driven Tracker ETF
QED
$1K ﹤0.01%
+48
New +$995
2022 Q4
0 quarters
CEMI
6220
DELISTED
Chembio diagnostics, Inc.
CEMI
$1K ﹤0.01%
3,520
+126
+4% +$38
2020 Q2
10 quarters
A icon
6221
CALL
Agilent Technologies
A
$47.3B
– –
-3,000
Closed -$365K –
AADR icon
6222
AdvisorShares Dorsey Wright ADR ETF
AADR
$37.6M
$0 ﹤0.01%
+1
New +$47
2022 Q4
0 quarters
ABEO icon
6223
Abeona Therapeutics
ABEO
$288M
$0 ﹤0.01%
14
-1
-7% -$4
2017 Q4
20 quarters
ACI icon
6224
CALL
Albertsons Companies
ACI
$5.7B
– –
-300,100
Closed -$7.46M –
ACNT icon
6225
Ascent Industries
ACNT
$124M
$0 ﹤0.01%
28
– –
2018 Q2
18 quarters

Similar funds

JP Morgan Chase's Q4 2022 Portfolio in Review

As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.

  • JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
  • JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
  • JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
  • JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
  • JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
  • JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
  • JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.

Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.